Literature DB >> 23821770

The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.

Andrey Anisimov1, Veli-Matti Leppänen, Denis Tvorogov, Georgia Zarkada, Michael Jeltsch, Tanja Holopainen, Seppo Kaijalainen, Kari Alitalo.   

Abstract

Vascular endothelial growth factors (VEGFs) regulate blood and lymphatic vessel development through VEGF receptors (VEGFRs). The VEGFR immunoglobulin homology domain 2 (D2) is critical for ligand binding, and D3 provides additional interaction sites. VEGF-B and placenta growth factor (PlGF) bind to VEGFR-1 with high affinity, but only PlGF is angiogenic in most tissues. We show that VEGF-B, unlike other VEGFs, did not require D3 interactions for high-affinity binding. VEGF-B with a PlGF-derived L1 loop (B-L1P) stimulated VEGFR-1 activity, whereas PlGF with a VEGF-B-derived L1 loop (P-L1B) did not. Unlike P-L1B and VEGF-B, B-L1P and PlGF were also angiogenic in mouse skeletal muscle. Furthermore, B-L1P also bound to VEGFR-2 and activated downstream signaling. These results establish a role for L1-mediated D3 interactions in VEGFR activation in endothelial cells and indicate that VEGF-B is a high-affinity VEGFR-1 ligand that, unlike PlGF, cannot efficiently induce signaling downstream of VEGFR-1.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23821770     DOI: 10.1126/scisignal.2003905

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  23 in total

1.  Blood vessel anastomosis is spatially regulated by Flt1 during angiogenesis.

Authors:  Jessica E Nesmith; John C Chappell; Julia G Cluceru; Victoria L Bautch
Journal:  Development       Date:  2017-03-01       Impact factor: 6.868

2.  Modulating Angiogenesis by Proteomimetics of Vascular Endothelial Growth Factor.

Authors:  Sami Abdulkadir; Chunpu Li; Wei Jiang; Xue Zhao; Peng Sang; Lulu Wei; Yong Hu; Qi Li; Jianfeng Cai
Journal:  J Am Chem Soc       Date:  2021-12-30       Impact factor: 15.419

3.  Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans.

Authors:  Sara Massena; Gustaf Christoffersson; Evelina Vågesjö; Cédric Seignez; Karin Gustafsson; François Binet; Carmen Herrera Hidalgo; Antoine Giraud; Jalal Lomei; Simone Weström; Masabumi Shibuya; Lena Claesson-Welsh; Pär Gerwins; Michael Welsh; Johan Kreuger; Mia Phillipson
Journal:  Blood       Date:  2015-08-18       Impact factor: 22.113

4.  Domain specificity of MAP3K family members, MLK and Tak1, for JNK signaling in Drosophila.

Authors:  Beth Stronach; Ashley L Lennox; Rebecca A Garlena
Journal:  Genetics       Date:  2014-01-15       Impact factor: 4.562

5.  VEGF Receptor-2 Activation Mediated by VEGF-E Limits Scar Tissue Formation Following Cutaneous Injury.

Authors:  Lyn M Wise; Gabriella S Stuart; Nicola C Real; Stephen B Fleming; Andrew A Mercer
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-08-01       Impact factor: 4.730

6.  Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B.

Authors:  Yinan Yang; Wencong Tian; Lei Yang; Qiong Zhang; Mengmeng Zhu; Yuansheng Liu; Jing Li; Liang Yang; Jie Liu; Yanna Shen; Zhi Qi
Journal:  J Cancer Res Clin Oncol       Date:  2020-09-08       Impact factor: 4.553

7.  VEGFB/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Obesity and Related Metabolic Complications.

Authors:  Marius R Robciuc; Riikka Kivelä; Ian M Williams; Jan Freark de Boer; Theo H van Dijk; Harri Elamaa; Feven Tigistu-Sahle; Dmitry Molotkov; Veli-Matti Leppänen; Reijo Käkelä; Lauri Eklund; David H Wasserman; Albert K Groen; Kari Alitalo
Journal:  Cell Metab       Date:  2016-04-12       Impact factor: 27.287

Review 8.  Mechanisms and regulation of endothelial VEGF receptor signalling.

Authors:  Michael Simons; Emma Gordon; Lena Claesson-Welsh
Journal:  Nat Rev Mol Cell Biol       Date:  2016-07-27       Impact factor: 94.444

9.  VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart.

Authors:  Riikka Kivelä; Maija Bry; Marius R Robciuc; Markus Räsänen; Miia Taavitsainen; Johanna M U Silvola; Antti Saraste; Juha J Hulmi; Andrey Anisimov; Mikko I Mäyränpää; Jan H Lindeman; Lauri Eklund; Sanna Hellberg; Ruslan Hlushchuk; Zhen W Zhuang; Michael Simons; Valentin Djonov; Juhani Knuuti; Eero Mervaala; Kari Alitalo
Journal:  EMBO Mol Med       Date:  2014-01-21       Impact factor: 12.137

Review 10.  Ziv-aflibercept in metastatic colorectal cancer.

Authors:  Anuj Patel; Weijing Sun
Journal:  Biologics       Date:  2013-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.